Katherine Anne Davoli

Mx. Katherine Anne Davoli

Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ACAudrey A. Chan
Audrey A. Chan
AHAndrew J. Hertsenberg
Andrew J. Hertsenberg
MFMartha L. Funderburgh
Martha L. Funderburgh
MMMary M. Mann
Mary M. Mann
YDYiqin Du
Yiqin Du
JFJames L. Funderburgh
James L. Funderburgh
Corneal transparency depends on a unique extracellular matrix secreted by stromal keratocytes, mesenchymal cells of neural crest lineage. Derivation of keratocytes from human embryonic stem (hES) cells could elucidate the keratocyte developmental pathway and open a potential for cell-based therapy for corneal blindness. This study seeks to identify conditions inducing differentiation of pluripotent hES cells to the keratocyte lineage. Neural differentiation of hES cell line WA01(H1) was induced by co-culture with mouse PA6 fibroblasts. After 6 days of co-culture, hES cells expressing cell-surface NGFR protein (CD271, p75NTR) were isolated by immunoaffinity adsorption, and cultured as a monolayer for one week. Keratocyte phenotype was induced by substratum-independent pellet culture in serum-free medium containing ascorbate. Gene expression, examined by quantitative RT-PCR, found hES cells co-cultured with PA6 cells for 6 days to upregulate expression of neural crest genes including NGFR, SNAI1, NTRK3, SOX9, and MSX1. Isolated NGFR-expressing cells were free of PA6 feeder cells. After expansion as a monolayer, mRNAs typifying adult stromal stem cells were detected, including BMI1, KIT, NES, NOTCH1, and SIX2. When these cells were cultured as substratum-free pellets keratocyte markers AQP1, B3GNT7, PTDGS, and ALDH3A1 were upregulated. mRNA for keratocan (KERA), a cornea-specific proteoglycan, was upregulated more than 10,000 fold. Culture medium from pellets contained high molecular weight keratocan modified with keratan sulfate, a unique molecular component of corneal stroma. These results show hES cells can be induced to differentiate into keratocytes in vitro. Pluripotent stem cells, therefore, may provide a renewable source of material for development of treatment of corneal stromal opacities.

1 September 2010 in Journal of Virology
Verified
Journal Article
Closed access
SRSrividya Ramachandran
Srividya Ramachandran
Katherine Anne DavoliKatherine Anne Davoli
Katherine Anne Davoli
MYMichael Yee
Michael Yee
RHRobert L. Hendricks
Robert L. Hendricks
PKPaul Kinchington
Paul Kinchington
Following herpes simplex virus type 1 (HSV-1) ocular infection of C57BL/6 mice, activated CD8 + T cells specific for an immunodominant epitope on HSV-1 glycoprotein B (gB-CD8 cells) establish a stable memory population in HSV-1 latently infected trigeminal ganglia (TG), whereas non-HSV-specific CD8 + T cells are lost over time. The retention and activation of gB-CD8 cells appear to be influenced by persistent viral antigenic exposure within the latently infected TG. We hypothesized that the low-level expression of gB from its native promoter before viral DNA synthesis is critical for the retention and activation of gB-CD8 cells in the TG during HSV-1 latency and for their ability to block HSV-1 reactivation from latency. To test this, we created a recombinant HSV-1 in which gB is expressed only after viral DNA synthesis from the true late gC promoter (gCp-gB). Despite minor growth differences compared to its rescuant in infected corneas, gCp-gB was significantly growth impaired in the TG and produced a reduced latent genome load. The gCp-gB- and rescuant-infected mice mounted similar gB-CD8 effector responses, but the size and activation phenotypes of the memory gB-CD8 cells were diminished in gCp-gB latently infected TG, suggesting that the stimulation of gB-CD8 cells requires gB expression before viral DNA synthesis. Surprisingly, late gB expression did not compromise the capacity of gB-CD8 cells to inhibit HSV-1 reactivation from latency in ex vivo TG cultures, suggesting that gB-CD8 cells can block HSV-1 reactivation at a very late stage in the viral life cycle. These data have implications for designing better immunogens for vaccines to prevent HSV-1 reactivation.

26 October 2022 in Journal of Virology
Verified
Journal Article
Open access
MSMadeline M. Schwarz
Madeline M. Schwarz
KCKaleigh A. Connors
Kaleigh A. Connors
Katherine Anne DavoliKatherine Anne Davoli
Katherine Anne Davoli
CMCynthia M. McMillen
Cynthia M. McMillen
JAJoseph R. Albe
Joseph R. Albe
AHAmy Hartman
Amy Hartman
Rift Valley fever virus (RVFV) infection leads to eye damage in humans in up to 10% of reported cases. Permanent blindness occurs in 50% of individuals with significant retinal scarring.

1 December 2002 in Journal of Histochemistry & Cytochemistry
Verified
Journal Article
Open access
PDF file
LBLynne M. Bianchi
Lynne M. Bianchi
KDKyl Dinsio
Kyl Dinsio
Katherine Anne DavoliKatherine Anne Davoli
Katherine Anne Davoli
NGNicholas W. Gale
Nicholas W. Gale
Immunostaining in transgenic mice carrying the lac z gene can be used to map gene and protein distribution in a single tissue. In this study, we examined inner ears from ephrin-B3 homozygous and ephrin-B2 heterozygous mice. Ephrin-B3 lac z expression was limited in these mice. However, immunostaining revealed ephrin-B3 throughout cochlear and vestibular regions. Immunoreactivity was absent in ephrin-B3-homozygous null mutants, demonstrating the specificity of the antibody. Ephrin-B2 lac z reactivity was detected in a limited number of cells in cochlear and vestibular regions. Different immunostaining patterns were found with different antibodies. Comparison with lac z expression indicated which antibody was specific for the transmembrane-bound ephrin-B2 ligand.

8 February 2024 in Experimental Eye Research
Verified
Journal Article
Closed access
BWBingjie Wang
Bingjie Wang
RARiley K. Arbuckle
Riley K. Arbuckle
Katherine Anne DavoliKatherine Anne Davoli
Katherine Anne Davoli
OCOwen D. Clinger
Owen D. Clinger
RBRichard Brown
Richard Brown
Shaohua PiShaohua Pi
Shaohua Pi

Verified
Journal Article
Open access
PDF file
JAJennifer O Adeghate
Jennifer O Adeghate
MEMichael Wayne Epperly
Michael Wayne Epperly
Katherine Anne DavoliKatherine Anne Davoli
Katherine Anne Davoli
KLKira L. Lathrop
Kira L. Lathrop
PWPeter Wipf
Peter Wipf
AEAndrew Eller
Andrew Eller
We hypothesize that the injection of JP4-039, a mitochondria-targeted nitroxide, prior to irradiation of the mouse retina may decrease apoptosis and reduce neutrophil and macrophage migration into the retina. In our study, we aimed to examine the effects of JP4-039 in the mouse retina using fluorescent microscopy, a terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay, and flow cytometry. Forty-five mice and one eye per mouse were used. In Group 1, fluorescent microscopy was used to determine retinal uptake of 10 µL (0.004 mg/µL) of intravitreally injected BODIPY-labeled JP4-039 at 0, 15, and 60 min after injection. In Group 2, the TUNEL assay was performed to investigate the rate of apoptosis after irradiation in addition to JP4-039 injection, compared to controls. In Group 3, flow cytometry was used to determine the extent of inflammatory cell migration into the retina after irradiation in addition to JP4-039 injection, compared to controls. Maximal retinal uptake of JP4-039 was 15 min after intravitreal injection (p < 0.0001). JP4-039-treated eyes had lower levels of retinal apoptosis (35.8 ± 2.5%) than irradiated controls (49.0 ± 2.7%; p = 0.0066) and demonstrated reduced migration of N1 cells (30.7 ± 11.7% vs. 77.7 ± 5.3% controls; p = 0.004) and M1 cells (76.6 ± 4.2 vs. 88.1 ± 3.7% controls, p = 0.04). Pretreatment with intravitreally injected JP4-039 reduced apoptosis and inflammatory cell migration in the irradiated mouse retina, marking the first confirmed effect of this molecule in retinal tissue. Further studies may allow for safety profiling and potential use for patients with radiation retinopathy.